Use: Labeled indications
- 1.
- Adults and Pediatric Patients
- Upper Respirtory Tract Infections of the Ear, Nose, and Throat Infections of the Genitourinary Tract Infections of the Skin and Skin Structure Infections of the Lower Respiratory Tract Adults Patients only
- Helicobacter pylori Infection and Duodenal Ulcer Disease Usage : To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be…
Full indications and usage US FDA label
1. INDICATIONS AND USAGE Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species. (α-and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae.
Infections of the Genitourinary Tract: Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis, or Enterococcus faecalis. Infections of the Skin and Skin Structure: Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp.
(α-and β-hemolytic isolates only), Staphylococcus spp., or E. coli. Infections of the Lower Respiratory Tract: Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp. (α-and β-hemolytic isolates only), S. pneumoniae, Staphylococcus spp., or H. influenzae.
Adults Patients only Helicobacter pylori Infection and Duodenal Ulcer Disease: Triple therapy for Helicobacter pylori (H. pylori) with clarithromycin and lansoprazole: Amoxicillin, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Dual therapy for H. pylori with lansoprazole: Amoxicillin, in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. (See the clarithromycin package insert, MICROBIOLOGY.) Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and other antibacterial drugs, Amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. AMOXICILLIN is a penicillin-class antibacterial indicated for treatment of infections due to susceptible strains of designated microorganisms.(1) Adults and Pediatric Patients (1) Upper Respirtory Tract Infections of the Ear, Nose, and Throat Infections of the Genitourinary Tract Infections of the Skin and Skin Structure Infections of the Lower Respiratory Tract Adults Patients only (1) Helicobacter pylori Infection and Duodenal Ulcer Disease Usage: To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
(1)
Contraindications
- Serious hypersensitivity (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin or other beta-lactams
Contraindications (US label) US FDA label
4 CONTRAINDICATIONS AMOXIL is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AMOXIL or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to Amoxicillin or to other beta-lactams (e.g., penicillins or cephalosporins). (4)
Dosing: Adult
- Adults (usual): 750 to 1,750 mg/day divided every 8 to 12 hours (for example 500 or 875 mg every 12 hours, or 250 or 500 mg every 8 hours)
- H. pylori triple therapy: 1 g amoxicillin + 500 mg clarithromycin + 30 mg lansoprazole, all every 12 hours for 14 days
- H. pylori dual therapy: 1 g amoxicillin + 30 mg lansoprazole every 8 hours for 14 days
- GFR below 30 mL/min: No 875 mg; 250–500 mg every 12 hours (10–30) or every 24 hours (below 10)
- In Adults, 750-1750 mg/day in divided doses every 8 to 12 hours. In Pediatric Patients over 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours. Refer to full prescribing information for specific dosing regimens. (2.2, 2.3)
- The upper dose for neonates and infants age 3 months or younger is 30 mg/kg/day divided every 12 hours. (2.3)
- Dosing for H. pylori Infection (in Adults): Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days. Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days. (2.4)
- Reduce the dose in patients with severe renal impairment (GFR greater than 30 mL/min). (2.5)
2.1 Important Administration Instructions
2.1 Important Administration Instructions To minimize the potential for gastrointestinal intolerance, Amoxicillin should be taken at the start of a meal.
2.2 Dosage for Adults and for Pediatric Patients Aged 3 Months (12 weeks) and Older
2.2 Dosage for Adults and for Pediatric Patients Aged 3 Months (12 weeks) and Older Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic, or evidence of bacterial eradication has been obtained. It is recommended that there be at least 10 days’ treatment for any infection caused by Streptococcus pyogenes to prevent the occurrence of acute rheumatic fever.
In some infections, therapy may be required for several weeks. It may be necessary to continue clinical and/or bacteriological follow-up for several months after cessation of therapy. Table 1. Dosage Recommendations for Adult and Pediatric Patients Aged 3 Months (12 weeks) and Older Infection Severity a Recommended Dosage for Adults and Pediatric Patients Aged 3 Months and Older and Weight Greater than 40 kg R ecommended Dosage for Pediatric Patients Aged 3 Months and Older and Weight Less than 40 kg Ear/Nose/Throat Skin/Skin Structure Genitourinary Tract Mild/Moderate 500 mg every 12 hour or 250 mg every 8 hours 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours Severe 875 mg every 12 hours or 500 mg every 8 hours 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours Lower Respiratory Tract Mild/Moderate or Severe 875 mg every 12 hours or 500 mg every 8 hours 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours a Dosage for infections caused by bacteria that are intermediate in their susceptibility to amoxicillin should follow the recommendations for severe infections.
2.3 Dosage in Pediatric Patients Aged Less than 12 Weeks (3 months)
2.3 Dosage in Pediatric Patients Aged Less than 12 Weeks (3 months) It is recommended that there be at least 10 days’ treatment for any infection caused by Streptococcus pyogenes to prevent the occurrence of acute rheumatic fever. Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided every 12 hours.
There are currently no dosing recommendations for pediatric patients with impaired renal function. Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic, or evidence of bacterial eradication has been obtained.
2.4 Dosing for H
2.4 Dosing for H. pylori Infection in Adults Triple therapy: The recommended adult oral dose is 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days. Dual therapy: The recommended adult oral dose is 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days.
Please refer to clarithromycin and lansoprazole full prescribing information.
2.5 Dosing in Renal Impairment for Adults and Pediatric Patients Aged 3 Months
2.5 Dosing in Renal Impairment for Adults and Pediatric Patients Aged 3 Months and Older and Weight Greater than 40 kg Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Renal impairment patients with a glomerular filtration rate of less than 30 mL/min should NOT receive the 875 mg dose.
See dosage regimens in patients with severe renal impairment provided in Table 2. Table 2. Dosing in Patients with Severe Renal Impairment Patients with Renal Impairment Dosage Regimen GFR 10 to 30 mL/min 500 mg or 250 mg every 12 hours, depending on the severity of the infection GFR less than 10 mL/min 500 mg or 250 mg every 24 hours, depending on severity of the infection Hemodialysis 500 mg or 250 mg every 24 hours, depending on severity of the infection Administer an additional dose both during and at the end of dialysis
2.6 Directions for Mixing Oral Suspension
2.6 Directions for Mixing Oral Suspension Prepare a suspension at time of dispensing as follows: Tap bottle until all powder flows freely. Measure the total amount of water (see Table 3). Add approximately 1/3 of the water to powder. Replace cap and shake vigorously to wet powder. Add remaining water and again shake vigorously.
Table 3. Amount of Water For Mixing Oral Suspension Strength Bottle Size Total Amount of Water Required for Reconstitution For Oral Suspension 200 mg/5 mL 50 mL 39 mL 75 mL 57 mL 100 mL 76 mL For Oral Suspension 400 mg/5 mL 50 mL 36 mL 75 mL 54 mL 100 mL 71 mL After reconstitution, the required amount of suspension should be placed directly on the child's tongue for swallowing.
Alternate means of administration are to add the required amount of suspension to formula, milk, fruit juice, water, ginger ale, or cold drinks. These preparations should then be taken immediately. SHAKE ORAL SUSPENSION WELL BEFORE USING. Keep bottle tightly closed. Any unused portion of the reconstituted suspension must be discarded after 14 days.
Refrigeration is preferable, but not required.
Dosing: Altered kidney function
Amoxicillin is mainly excreted unchanged in urine (about 60% of an oral dose in 6 to 8 hours). The US label needs no dose change unless kidney impairment is severe: below a GFR of 30 mL/min do not use the 875 mg dose, give 250 or 500 mg every 12 hours (GFR 10–30) or every 24 hours (below 10), and give extra doses during and after hemodialysis.
Kidney function measure: Label states GFR in mL/min (not indexed); cut-offs 30 and 10. Shown in the CrCl band rows.
Show full dosing details
- CrCl ≥60 mL/min
- No dose change (label).
- CrCl 30–59 mL/min
- No dose change; the label reduces dose only below GFR 30 (label).
- CrCl 15–29 mL/min
- GFR 10–30: 500 mg or 250 mg every 12 hours by severity; do not use the 875 mg dose (label).
- CrCl <15 mL/min (not on dialysis)
- GFR 10–14: 500 mg or 250 mg every 12 hours. GFR below 10: 500 mg or 250 mg every 24 hours by severity. No 875 mg dose (label).
- Hemodialysis (intermittent)
- 500 mg or 250 mg every 24 hours by severity, plus an additional dose both during and at the end of dialysis (label).
- Peritoneal dialysis
- No peritoneal dialysis dosing in label. For PD-associated peritonitis (ISPD 2022): continuous intraperitoneal maintenance dose 150 mg/L in each exchange; no intermittent data. Specialist input.
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Yes: may be removed by hemodialysis (label). About 20% protein bound.
- Monitoring Kidney function for dose; rash; diarrhea (CDAD); INR with oral anticoagulants (label). Crystalluria and interstitial nephritis reported after overdose; keep fluid intake up.
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- Usual pediatric dose (label).
- eGFR 30–59
- No dosing recommendations for children with kidney impairment (label). Specialist input.
- eGFR 15–29
- No dosing recommendations for children with kidney impairment (label). Specialist input.
- eGFR <15 (not on dialysis)
- No dosing recommendations for children with kidney impairment (label). Specialist input.
- Hemodialysis (intermittent)
- No dosing recommendations for children with kidney impairment (label). Specialist input.
- Peritoneal dialysis
- No dosing recommendations for children with kidney impairment (label). Specialist input.
- CRRT
- No dosing recommendations for children with kidney impairment (label). Specialist input.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
US label text: Renal impairment US FDA label
2.5 Dosing in Renal Impairment for Adults and Pediatric Patients Aged 3 Months and Older and Weight Greater than 40 kg Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Renal impairment patients with a glomerular filtration rate of less than 30 mL/min should NOT receive the 875 mg dose.
See dosage regimens in patients with severe renal impairment provided in Table 2. Table 2. Dosing in Patients with Severe Renal Impairment Patients with Renal Impairment Dosage Regimen GFR 10 to 30 mL/min 500 mg or 250 mg every 12 hours, depending on the severity of the infection GFR less than 10 mL/min 500 mg or 250 mg every 24 hours, depending on severity of the infection Hemodialysis 500 mg or 250 mg every 24 hours, depending on severity of the infection Administer an additional dose both during and at the end of dialysis
Dosing: Pediatric
- Approved ages
- All ages, including neonates (label).
- Usual dose
- 12 weeks (3 months) or younger: up to 30 mg/kg/day divided every 12 hours (immature kidney function) (label 2.3). Over 3 months: 20 to 45 mg/kg/day divided every 8 to 12 hours, by infection and severity; 40 kg or more: adult dose (label).
- Maximum dose
- Adult dose (label).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedAdministration
2.1 Important Administration Instructions To minimize the potential for gastrointestinal intolerance, Amoxicillin should be taken at the start of a meal.
US FDA labelDosage forms
Philippines
- Capsule: 250 mg, 500 mg
- Powder for suspension: 100 mg per mL, 100 mg/mL, 125 mg/5 mL, 250 mg/5 mL
- Powder for oral suspension: 100 mg/mL, 125 mg/5 mL, 125 mg/mL, 250 mg per 5 mL, 250 mg/5 mL
- Granule for suspension: 125 mg/5 mL, 250 MG/5 ML, 250 mg/mL
- Dispersible tablet for oral suspension: 125 mg, 250 mg
- Granule for oral suspension: 125 mg/5 mL, 250 mg/5 mL
- Powder for solution: 250 mg/5 mL
Registered products in the Philippines
260 products registered with the Food and Drug Administration (FDA) Philippines list Amoxicillin as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Amoxicililn (as trihydrate) (1 product). Products registered under these spellings are included in the table and marked.
All registered products260
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AcumoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY17423-B | Aug 22, 2027 | |
AcumoxAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY16958-B | Sep 20, 2027 | |
AdmoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | LLOYD LABORATORIES, INC.Philippines | ADVANCE PHARMA DISTRIBUTION CORP.Trader: FORAMEN PRODUCTS CORPORATION | DRP-312-03 | Sep 22, 2031 | |
AltomoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL Box of 1's | Rx | LLOYD LABORATORIES, INC.Philippines | Altomed Pharmaceuticals, Inc.Trader: FORAMEN PRODUCTS CORPORATION | DRP-1173-01 | May 21, 2029 | |
AltomoxAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Foramen Products Corporation | DRP-313-02 | May 21, 2029 | |
AltomoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Foramen Products Corporation | DR-XY46976 | Aug 6, 2030 | |
AltomoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Foramen Products Corporation | DRP-312-02 | Sep 3, 2031 | |
AmbimoxAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | AMB HK Enterprises Inc. | DRP-9966 | Feb 8, 2029 | |
AmmocilAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-9966-01 | Feb 8, 2029 | |
AmoppexAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Dropper x 10 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Appex MD's Pharmaceutical Inc. | DRP-1217-08 | Jun 28, 2027 | |
AmoppexAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Appex MD's Pharmaceutical Inc. | DRP-1425-15 | Nov 21, 2026 | |
AmorexAmoxicillin (as Trihydrate) | 100mg/mL Powder for Suspension (Oral Drops)Amber glass bottle with dropper x 10mL in 15mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-5253 | Nov 19, 2027 | |
AmorexAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-5251 | Feb 28, 2027 | |
AmorexAmoxicillin (as trihydrate) | 250 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Drugmaker’s Laboratories Inc.Laguna | — | DRP-5244 | Feb 13, 2032 | |
AmorexAmoxicillin (as Trihydrate) | 250 mg/5mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker’s Laboratories, Inc.Philippines | — | DRP-5258 | Feb 23, 2030 | |
AmoxdenAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Cyden Medicale Trading Inc.Importer: AMB HK Enterprises Inc. | DRP-9966-02 | Feb 8, 2029 | |
AmoxilAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 20's and 100's); 3 Capsules per Blister Pack as Physician's Sample | Rx | Glaxo Wellcome ProductionFrance | Importer: GlaxoSmithKline Philippines, Inc. | DRP-6461 | Mar 10, 2031 | |
Amoxillen-100Amoxicillin | 100 mg per mL Powder for Suspension (Oral Drops)Amber Bottle x 60 mL & 70 mL (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-17648 | Feb 11, 2031 | |
Amoxillen-250Amoxicillin | 250 mg per 5mL Powder for Oral SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-17681 | Feb 16, 2031 | |
AmoxipenAmoxicillin (as Trihydrate) | 100 mg/mL Powder For Suspension (Oral Drops)Box of 10 mL Amber Glass Bottle with dropper | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | ZEUTICA, INC. | DRP-1217-06 | Jun 28, 2027 | |
AMOXIPENAMOXICILLIN (AS TRIHYDRATE) | 250MG/5ML POWDER FOR SUSPENSION | Rx | J.M. TOLMANN LABORATORIES INC. | ZEUTICA , INC. | DRP-1425-08 | Nov 21, 2026 | |
AmoxipenAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Zeutica, Inc. | DRP-1475-02 | May 10, 2027 | |
Amoxirite-500Amoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Pharmatechnica Laboratory, Inc.Philippines | Ritegen Inc. | DRP-11875-01 | Nov 14, 2028 | |
Amoxollen 500Amoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-16610 | May 15, 2030 | |
Amoxollen-125Amoxicillin (as Trihydrate) | 125 mg/5mL Powder for Oral SuspensionAmber Boston Bottle x 60mL & 70mL (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-16611 | May 15, 2030 | |
Amoxollen-250Amoxicillin (As Trihydrate) | 250 mg CapsuleAlu/AluPvc Blister Of 10'S (box of 100's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-18577 | Aug 3, 2031 | |
Amoxsaph-10Amoxicillin (as trihydrate) | 100 mg/mL Powder for Oral SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd | DRP-6700 | May 18, 2031 | |
Amoxsaph-125Amoxicillin (as trihydrate) | 125 mg/mL Powder for Oral SuspensionAmber Bottle x 60 mL and 70 mL (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd | DRP-6699 | May 18, 2031 | |
Amoxsaph-250Amoxicillin (as trihydrate) | 250 mg/5 mL Powder for Oral SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's); Boston Round Amber Bottle x 70 mL (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | NELPA LIFESCIENCES, INC. | DRP-4909 | Dec 17, 2028 | |
AmoxstanAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Westfield Pharmaceuticals, Inc. | DRP-1431-09 | Aug 2, 2027 | |
Amoxsur 500Amoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharma-Surrey International, Inc. | DRP-16245 | Jan 9, 2030 | |
AmsolinAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | North China Pharmaceutical Co., Ltd.China | Amson PharmaceuticalsImporter: Nueva Sunshine Phils., Inc. | DRP-3358-01 | Mar 31, 2029 | |
AxiomaceAmoxicillin (as trihydrate) | 250 mg CapsuleAlu/PVC blister pack x 10's (Box of 100's) | Rx | Uni MedicolabsIndia | Greencore Pharma Inc. | DRP-14917 | Feb 13, 2029 | |
AxmelAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL Amber Glass Bottle with 1 mL Plastic Dropper Box of 1's | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-094 | Feb 1, 2030 | |
AxmelAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-095 | Apr 5, 2030 | |
AxmelAmoxicillin (as trihydrate) | 250 mg CapsuleClear PVC & Printed Aluminum Foil Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-237 | Oct 29, 2030 | |
AxmelAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for Suspension (Pineapple Flavor)Amber Glass Bottle x 60 mL Box of 1's | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-097 | Jan 8, 2030 | |
AxmelAmoxicillin (as trihydrate) | 500 mg CapsuleAlu-PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-207 | Oct 1, 2030 | |
BACTIGENTAMOXICILLIN (TRIHYDRATE) | 250MG/5ML POWDER FOR SUSPENSION | Rx | J.M. TOLMANN LABORATORIES INC. | FILADAMS PHARMA INC. | DRP-1425-06 | Nov 21, 2026 | |
BactigentAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Flamingo Pharmaceuticals Ltd.India | Filadams Pharma, Inc.Importer: Hexagon Pharmaceuticals | DRP-316-03 | Mar 10, 2029 | |
Bactigent 500Amoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Filadams Pharma, Inc. | DRP-1431-10 | Aug 2, 2027 | |
BenedexAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10mL with Medicine Dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29690 | Jun 21, 2029 | |
BenedexAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29721 | Jul 6, 2029 | |
BenedexAmoxicillin (as trihydrate) | 250 mg CapsuleClear PVC & Printed Aluminum Foil Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-237-02 | Aug 1, 2031 | |
BenedexAmoxicillin (as trihydrate) | 250mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29691 | Jun 22, 2029 | |
BenedexAmoxicillin (as trihydrate) | 500mg CapsuleAlu-PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-207-03 | Jul 26, 2031 | |
BetamoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL Amber Glass Bottle with 1 mL Plastic Dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-094-03 | Feb 1, 2030 | |
BetamoxAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-095-04 | Apr 1, 2031 | |
BetamoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-097-04 | Jan 8, 2030 | |
BetamoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu-PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Latriel Corporation | DRP-207-06 | Jul 14, 2031 | |
BritamoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Philgen Pharmaceuticals Inc. | DRP-1969 | Feb 23, 2031 | |
BroadmetzAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DR-XY17459-B | Sep 14, 2027 | |
BroadmetzAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Bottle x 60 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DRP-9934 | Sep 18, 2027 | |
BroadmetzAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DR-XY17246-B | Sep 18, 2027 | |
BroadmetzAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DR-XY15678-B | Sep 18, 2027 | |
BroadmetzAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DR-XY46971 | Aug 6, 2030 | |
BrospecAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's Box of 100's | Rx | Scheele Laboratories Phils., Inc.Philippines | — | DRP-10173 | Feb 6, 2028 | |
Brumox-250Amoxicillin (as trihydrate) | 250 mg CapsuleAlu/Clear PVC Blister Pack x 10’s (Box of 100’s) | Rx | Brawn Laboratories LimitedIndia | Ambica International Corporation | DRP-4644 | Sep 2, 2028 | |
Brumox-500Amoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation | DRP-4087 | Nov 6, 2027 | |
CycamilAmoxicillin (as trihydrate) | 125 mg/5mL Powder for Oral SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Drugmaker’s Laboratories, Inc.Philippines | — | DR-XY7703 | Jan 27, 2030 | |
CycamilAmoxicillin (as trihydrate) | 250 mg CapsuleAlu/PVC Blister pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-8135 | Feb 24, 2028 | |
DaisamoxAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Metro Manila | Pharmacare Products Corporation | DRP-1425-11 | Nov 21, 2031 | |
DroxylAmoxicillin (as trihydrate) | 250mg CapsuleBlister pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-8410 | May 11, 2027 | |
DroxylAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-7925 | Apr 5, 2027 | |
EleomoxAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY19555 | Feb 1, 2027 | |
EleomoxAmoxicillin (as trihydrate) | 125 mg/5 mL Granules for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY23284 | Sep 11, 2027 | |
EleomoxAmoxicillin (as Trihydrate) | 250 mg/5 mL Granules for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Trader: Vamsler Phils. Incorporated | DR-XY23763 | Jan 19, 2032 | |
EleomoxAmoxicillin (as Trihydrate) | 500 mg CapsuleAluminum Foil Strip x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY10086 | Apr 10, 2027 | |
EleomoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils., Incorporated | DR-XY46974 | Mar 15, 2031 | |
EllaxinAmoxicillin (as trihydrate) | 100mg/mL Powder for Suspension (Oral Drops)Box of 10 mL Amber Glass Bottle with dropper | Rx | J.M. Tolmann Laboratories, Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-1217-07 | Jun 28, 2027 | |
EllaxinAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | 999 SETH PHARMACEUTICAL INC. | DRP-1425-10 | Nov 21, 2031 | |
Elmox 500Amoxicillin (as Trihydrate) | 500mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-9538 | Mar 3, 2031 | |
EppitrexilAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL Amber Glass Bottle with 1 mL Plastic Dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-094-05 | Feb 1, 2030 | |
EppitrexilAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-095-07 | Mar 6, 2031 | |
EppitrexilAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-097-07 | Jan 8, 2030 | |
EppitrexilAmoxicillin (as trihydrate) | 500 mg CapsuleAlu-PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-207-07 | Aug 7, 2031 | |
EuramoxAmoxicillin (as trihydrate) | 100mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1’s) | Rx | EURASIA RESEARCH PHARMA CORPORATIONPhilippines | — | DR-XY46209 | Dec 20, 2028 | |
EuramoxAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Eurasia Research Pharma CorporationPhilippines | — | DR-XY46208 | Jan 3, 2028 | |
EuramoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | EURASIA RESEARCH PHARMA CORPORATIONPhilippines | — | DR-XY46207 | Dec 20, 2028 | |
EvimoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Bottle x 60 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Philippine Home Pharmaceuticals | DR-XY17394 | Mar 20, 2028 | |
EvimoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Philippine Home Pharmaceutical | DR-XY17409 | Nov 22, 2027 | |
ExbropinAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Drops)Amber Glass Bottle x 10 mL with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals Phils., Inc. | DR-XY19330 | Apr 23, 2027 | |
ExbropinAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DR-XY19467 | Jan 5, 2030 | |
ExbropinAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DR-XY46978 | Aug 6, 2030 | |
ExbropinAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-2392 | Jan 19, 2030 | |
FermoxilAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Ferma Drug Enterprises | DRP-1431-08 | Aug 2, 2027 | |
FulmoxAmoxicillin (as trihydrate) | 125 mg / 5 mL Powder for Oral Suspension (Strawberry flavor)Amber Glass Bottle x 60 mL Box of 1's | Rx | Diamond Laboratories Inc.Philippines | Full Health International Pharma | DRP-2690-01 | Oct 30, 2027 | |
FulmoxAmoxicillin (as trihydrate) | 250 mg / 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL Box of 1's | Rx | Diamond Laboratories Inc.Philippines | Full Health International Pharma | DRP-248-02 | Aug 21, 2027 | |
Gimox-500Amoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Gijun Trading Inc. | DRP-1431-11 | Aug 2, 2027 | |
GiomoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Euro-Care products PhilippinesTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-2392-02 | Jan 19, 2030 | |
GLOBAPENAMOXICILLIN (AS TRIHYDRATE) | 250MG/5ML GRANULES FOR SUSPENSION | Rx | HIZON LABORATORIES, INC. | Trader: GX INTERNATIONAL, INC. | DR-XY18414-B | Jan 24, 2027 | |
GorgonioAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-4087-03 | Nov 6, 2027 | |
HamoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Harlem SalesImporter: Philgen Pharmaceuticals, Inc. | DRP-1969-08 | Feb 23, 2031 | |
HarbimoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DR-XY38394 | Aug 20, 2027 | |
HealthcareAmoxicillin (as trihydrate) | 125 mg/5 mL Granules for SuspensionHDPE Plastic Bottle x 105 mL with Measuring Cup 20 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY39558 (For Export Only) | Jun 2, 2030 | |
HealthcareAmoxicillin (as trihydrate) | 250 mg/5 mL Granules for SuspensionHDPE Plastic Bottle x 105 mL with Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY40219 (For Export Only) | Oct 20, 2031 | |
Healthcare Amoxicillin 500Amoxicillin (as Trihydrate) | 500 mg CapsuleClear PVC Blister Pack x 21's (Box of 21's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY39449 (For Export Only) | May 13, 2030 | |
HimoxAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber glass bottle x 60 mL and 105 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY12740 | May 10, 2029 | |
HimoxAmoxicillin (as trihydrate) | 250 mg CapsuleAluminum Blister Pack x 10's (Box of 100's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY12737 | Dec 18, 2027 | |
HimoxAmoxicillin (as trihydrate) | 250 mg/ 5 mL Powder for SuspensionAmber glass bottle x 60 mL and 105 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY12741 | Mar 24, 2029 | |
500 mg CapsuleAlu/ PVC Blister Pack x 10's (Box of 100's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY12738 | Apr 15, 2031 | ||
LewixinAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Trader: Lewison Pharmaceuticals Corporation | DR-XY21293 | May 14, 2032 | |
LimohexAmoxicillin (as trihydrate) | 500 mg CapsuleAlu / PVC Blister Pack x 10’s (Box of 100’s) | Rx | Flamingo Pharmaceuticals Ltd.India | Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals | DRP-316-05 | Mar 10, 2029 | |
LimoxilAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Flamingo Pharmaceuticals Ltd.India | TRUMED PHARMACEUTICALSImporter: HEXAGON PHARMACEUTICALS | DRP-316-04 | Mar 10, 2029 | |
LittmoxAmoxicillin (as Trihdyrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Littman Drug Corporation | DR-XY28023 | Nov 8, 2027 | |
MaelenoxylAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10mL (Box of 1's) | Rx | LLOYD LABORATORIES, INC.Philippines | Trader: Foramen Products Corporation | DRP-1173 | May 21, 2029 | |
MaelenoxylAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | LLOYD LABORATORIES, INC.Philippines | DHAN-CZAR MARKETINGTrader: Foramen Products Corporation | DRP-313 | May 21, 2029 | |
MaelenoxylAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | D And JB Pharma Medica Corp.Trader: Foramen Products Corporation | DRP-312 | Nov 3, 2031 | |
MedimoxilAmoxicillin (as trihydrate) | 100 mg /mL Powder for Suspension (Oral Drops)10mL in 15 mL- capacity Type III Borosilicate amber bottle (Box of 1's); 15mL in 30mL-capacity Type III Borosilicate amber bottle (Box of 1's) | Rx | Fortis Medi Pharmaceutical, Inc.Philippines | MG Prime Pharmaceutical, Inc. | DR-XY46659 | Aug 15, 2029 | |
MedimoxilAmoxicillin (as trihydrate) | 125 mg/5mL Granules for Oral SuspensionType III Borosilicate amber bottle x 60 mL (Box of 1's) | Rx | Fortis Medi Pharmaceutical, IncPhilippines | MG Prime Pharmaceutical, Inc. | DR-XY46632 | Jul 1, 2029 | |
MedimoxilAmoxicillin (as trihydrate) | 250 mg/5 mL Granules for Oral SuspensionType III Borosilicate amber bottle x 60 mL Box of 1's | Rx | Fortis Medi Pharmaceutical, Inc.Philippines | MG Prime Pharmaceutical, Inc. | DR-XY46630 | Jul 1, 2029 | |
MedomoxAmoxicillin (as trihydrate) | 125 mg Dispersible Tablet for Oral SuspensionIn Box of 2 PVC Blister pack x 10's | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-9248 | Oct 22, 2030 | |
MedomoxAmoxicillin (as trihydrate) | 250 mg Dispersible Tablet for Oral SuspensionIn Box of 2 PVC Blister pack x 10's Box of 20's | Rx | Medopharm Private Limited (Unit II)India | MedEthix, Inc. | DRP-8846 | May 15, 2030 | |
MedvoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Dropper x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma Inc. | DR-XY20025 | Jun 14, 2027 | |
MedvoxAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Bottle x 60mL with Aluminum Cap and Secondary Box | Rx | Lloyd Laboratories, Inc.Bulacan | Trader: Medhaus Pharma, Inc. | DR-XY18412 | Jun 4, 2031 | |
MedvoxAmoxicillin (as trihydrate) | 250 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Inc. | DR-XY17397 | Oct 30, 2031 | |
MedvoxAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle (60 mL) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY16334 | Dec 14, 2030 | |
MedvoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY16132 | Dec 5, 2030 | |
MedvoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY46970 | Aug 6, 2031 | |
MegamoxAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Pharma Dynamic, Inc. | DR-XY14188 | Jan 22, 2028 | |
MetamoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-14971-01 | Feb 28, 2029 | |
MoksAmoxicillin (as Trihydrate) | 500mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Singapore Pharmawealth Lifesciences, Inc.Philippines | Phil. Pharmawealth, Inc. | DR-XY27113 | Aug 23, 2029 | |
Mox-SAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's); Blister Pack x 21's (Box of 21's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Starpharm, Inc. | DRP-1475-04 | May 10, 2027 | |
MoxedAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | 777 Red Pharma Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-1969-07 | Feb 23, 2031 | |
MoxethAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | 777 Red Pharma IncImporter: Nelpa Lifesciences, Inc. | DRP-8388-01 | Aug 4, 2031 | |
Moxeth-250Amoxicillin (as Trihydrate) | 250 mg/5 mL Powder for Oral SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | Sapphire Lifesciences Pvt. LtdIndia | 777 Red Pharma, Inc.Importer: Nelpa Lifesciences, Inc. | DRP-4909-01 | Dec 17, 2028 | |
MoxicureAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu / Clear PVC Blister Pack x 10's (Box of 100's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-9966-03 | Feb 8, 2029 | |
Moxill 250Amoxicillin (as trihydrate) | 250 mg / 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Care First Trading | DRP-1425-14 | Nov 21, 2031 | |
Moxillin 500Amoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Care First Trading | DRP-1431-06 | Aug 2, 2027 | |
Moxinova-125Amoxicillin(As Trihydrate) | 125 mg / 5 mL Powder For Oral Suspension (Pineapple flavor)70 mL-Capacity HDPE Bottle with fitted plastic plug and closed with cap + 10 mL-capacity measuring cup (Box of l's) | Rx | Yeluri Formulations Pvt Ltd.India | Medinova Pharmaceutical Inc. | DRP-12863 | Oct 18, 2027 | |
Moxinova-250Amoxicillin(As Trihydrate) | 250 mg/5mL Powder For Oral Suspension (Pineapple flavor)70 mL-Capacity HDPE Bottle with fitted plastic plug and closed with cap + 10 mL-capacity measuring cup (Box of l's) | Rx | Yeluri Formulations Pvt Ltd.India | Medinova Pharmaceutical Inc. | DRP-12865 | Oct 18, 2027 | |
MoxydrilAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Sydenham Laboratories, Inc.Philippines | Trader: Sydenham Pharmaceuticals, Inc. | DRP-777 | Dec 2, 2027 | |
MoxylorAmoxicillin (as trihydrate) | 125 mg / 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories, Inc.Philippines | Rilem Pharma Corp. | DRP-7157 | Mar 7, 2031 | |
MoxylorAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for Oral Suspension (Strawberry Flavor)75 mL HDPE Bottle with LDPE Cap (Box of 1’s) | Rx | Diamond Laboratories, Inc.Philippines | Rilem Pharma Corp | DRP-18051 | Apr 29, 2031 | |
MoxylorAmoxicillin (as trihydrate) | 250 mg / 5 mL Powder for Oral Suspension (Strawberry Flavor)75 mL-capacity HDPE bottle with LDPE cap containing 60 mL net content (Box of l's) | Rx | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-12868 | Oct 18, 2027 | |
MoxylorAmoxicillin (as trihydrate) | 250 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Diamond Laboratories Inc.Philippines | — | DRP-7816 | Mar 6, 2031 | |
MoxylorAmoxicillin (as trihydrate) | 250 mg/ 5 mL Powder for SuspensionAmber Bottle x 60 mL Box of 1's | Rx | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-7061 | Apr 18, 2030 | |
MoxylorAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Diamond Laboratories Inc.Philippines | — | DRP-7272 | Sep 27, 2030 | |
MusitalAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmbr Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Westfield Pharmaceuticals, Inc. | DRP-8465-01 | Sep 27, 2027 | |
MusitalAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Westfield Pharmaceuticals, Inc. | DRP-5147-03 | Sep 19, 2027 | |
NixolinAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Pryce Pharmaceuticals, Inc.Trader: Euro-Health Care Exponents, Inc. | DR-XY26111 | Apr 12, 2030 | |
NoneAmoxicillin (as trihydrate) | 100 mg/ mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY12739 | May 26, 2031 | |
NoneAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral drops)Amber glass bottle with dropper x 10 mL in 15 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-5253-01 | Nov 19, 2027 | |
NoneAmoxicillin (as trihydrate) | 125 mg Dispersible Tablet for Oral SuspensionIn box of 2 PVC Blister pack x 10's | Rx | Medopharm Private LimitedIndia | Medethix, Inc. | DRP-9249 | Oct 22, 2030 | |
NoneAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY12418 | Aug 11, 2028 | |
NoneAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories Inc.Philippines | — | DRP-2690 | Oct 30, 2027 | |
NoneAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-5251-01 | Feb 28, 2027 | |
NoneAmoxicillin (as trihydrate) | 125mg/5mL Granules for Oral SuspensionType III Borosilicate Amber Bottle x 60mL (Box of 1's) | Rx | Fortis Medi Pharmaceutical, IncPhilippines | Importer: RICH GEM PHARMA INC. | DR-XY46631 | Jul 1, 2029 | |
NoneAmoxicillin (As Trihydrate) | 250 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY12415 | Mar 28, 2027 | |
NoneAmoxicillin (as trihydrate) | 250 mg CapsuleAlu / PVC blister pack x 10's (Box of 100's) | Rx | Uni MedicolabsIndia | Qualifirst Health Inc.Importer: Greencore Pharma Inc. | DRP-14917-01 | Feb 13, 2029 | |
NoneAmoxicillin (as trihydrate) | 250 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-5244-01 | Feb 13, 2027 | |
NoneAmoxicillin (as trihydrate) | 250 mg Dispersible Tablet for Oral SuspensionIn Box of of 2 Blister Pack x 10's | Rx | Medopharm Private Limited (Unit II)India | MedEthix, Inc. | DRP-8847 | May 15, 2030 | |
NoneAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle X 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc. | DRP-1425-17 | Nov 21, 2026 | |
NoneAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories Inc.Philippines | — | DRP-248 | Aug 21, 2027 | |
NoneAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister pack x 10's (Box of 100's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY12414 | Feb 27, 2027 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Dyna Drug Corporation | DR-XY21939 | Sep 19, 2027 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Actimed, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-10399 | Mar 15, 2031 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Rose Pharmacy, IncorporatedTrader: Innogen Pharmaceuticals, Inc. | DRP-10399-01 | Apr 16, 2031 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | St. Joseph DrugstoreTrader: Innogen Pharmaceuticals, Inc. | DRP-10399-03 | Jun 3, 2031 | |
NoneAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's); Blister Pack x 21's (Box of 21's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Red Drug Pharmaceutical Inc | DRP-1475-03 | May 10, 2027 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dyna Drug CorporationImporter: AMB HK Enterprises Inc. | DRP-14971-02 | Feb 28, 2029 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu / PVC Blister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Qualifirst Health Inc.Importer: AMB HK Enterprises Inc. | DRP-14971-03 | Feb 28, 2029 | |
NoneAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Farmacia Ni Dok, Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-1969-05 | Feb 8, 2032 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10’s (Box of 100’s) | Rx | Diamond Laboratories Inc.Philippines | — | DRP-247 | Sep 2, 2028 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4087-07 | Nov 6, 2027 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-5147-01 | Sep 19, 2027 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu-PVC Blister Pack x 10's (Box of 100's) | Rx | Glaxo Wellcome ProductionFrance | Philusa CorporationImporter: GlaxoSmithKline Philippines, Inc. | DRP-6461-01 | Mar 10, 2031 | |
NoneAmoxicillin | 500 mg CapsuleBlister Pack x 20's (Box of 100's) | Rx | Vonwelt Inc.Philippines | — | DRP-7041 | Feb 28, 2028 | |
NoneAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Actimed, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-7497 | Apr 5, 2028 | |
NoneAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | St. Joseph DrugstoreTrader: Innogen Pharmaceuticals, Inc. | DRP-7497-01 | Apr 5, 2028 | |
NoneAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Rose Pharmacy, IncorporatedTrader: Innogen Pharmaceuticals, Inc. | DRP-7497-02 | Apr 5, 2028 | |
NoneAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | South Star DrugTrader: Innogen Pharmaceuticals, Inc. | DRP-7497-03 | Apr 5, 2028 | |
NoneAmoxicillin (as trihydrate) | 500mg CapsuleAlu/PVC Blister pack x 10's Box of 100's | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-7925-01 | Apr 5, 2027 | |
NuevamoxilAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | North China Pharmaceutical Co., Ltd.China | Sahar International Trading Inc.Importer: Nueva Sunshine Phils., Inc. | DRP-3358 | Mar 31, 2029 | |
Nuevamoxil-DSAmoxicillin (as trihydrate) | 250 mg/mL Granules for SuspensionAmber HDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | North China Pharmaceutical Co., Ltd.China | Sahar International Trading Inc.Importer: Nueva Sunshine Phils., Inc | DRP-7731 | Sep 22, 2028 | |
PediamoxAmoxicillin (as trihydrate) | 100 mg / mL Powder for Suspension (Oral Drops)Amber bottle x 10 mL Box of 1's | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-X9100 | Feb 16, 2029 | |
PediamoxAmoxicillin (as trihydrate) | 250 mg/ 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL and 105 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-X8346 | Jun 25, 2028 | |
PediaxilAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Colored PET Bottle x 60 mL (Box of 1's) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-984 | Nov 17, 2031 | |
Pediaxil ForteAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Colored PET Bottle x 60mL (Box of 1's) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-977 | Nov 14, 2036 | |
PrimexAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Primera Pharma, Corp. | DR-XY19458 | Jan 5, 2030 | |
PrimexAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Bottle x 60 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Primera Pharma, Corp. | DR-XY19192 | Jun 5, 2027 | |
PrimexAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Primera Pharma Corporation | DR-XY18915 | Aug 16, 2027 | |
PromoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for Oral SuspensionAmber Glass Bottle x 60 mL and 105 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Heltker A.G. Corporation | DR-XY17579-B | Jul 7, 2027 | |
PromoxAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Heltker A.G. Corporation | DR-XY17580-B | Jul 3, 2027 | |
QuinlinAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4087-06 | Nov 6, 2027 | |
RichmoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation | DRP-4087-02 | Nov 6, 2027 | |
RielmoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Trader: Transcend Phils., Inc. | DR-XY17389 | Jan 30, 2032 | |
RielmoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DR-XY15192 | Dec 29, 2029 | |
RielmoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DR-XY46972 | Aug 6, 2030 | |
Saphmox 500Amoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8388 | Aug 4, 2031 | |
SavermoxAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Better Option Pharmaceuticals, Inc.Importer: Philgen Pharmaceuticals, Inc. | DRP-1969-03 | Feb 23, 2031 | |
Seamox 500Amoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-12297 | Jul 20, 2027 | |
SemoxilAmoxicillin (as trihydrate) | 500 mg CapsuleAlu-PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-207-04 | Jul 21, 2031 | |
Semoxil 1-6Amoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-095-02 | Apr 5, 2031 | |
Semoxil 7-12Amoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-097-02 | Jan 8, 2030 | |
SitimoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu-PVC Blister Pack of 10's (Box of 100's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., LtdChina | Sahar International Trading, Inc. | DR-XY48738 | May 22, 2028 | |
SpamoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/clear PVC Blister Pack x 10's (Box of 100's) | Rx | Sparsh Bio-Tech Pvt. Ltd.India | Khriz Pharma Trading, Inc. | DR-XY48720 | May 8, 2028 | |
SpamoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/clear PVC blister pack x 10's (Box of 100's) | Rx | Sparsh Bio-Tech Pvt. LtdIndia | Khriz Pharma Trading Inc. | DRP-17951 | May 8, 2028 | |
SpectraAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | Trader: APT DRUGS TRADING | DR-XY38041 | Aug 5, 2028 | |
SpectraAmoxicillin (as trihydrate) | 500mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. TOLMANN, INC.Philippines | APT DRUGS TRADING | DRP-1431-05 | Aug 2, 2027 | |
SupramoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL with dropper Box of 1's | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Euro-Health Care Exponents, Inc. | DR-XY43036 | Nov 28, 2028 | |
SupramoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Euro-Health Care Exponents, Inc. | DR-XY20187-B | Jun 23, 2027 | |
SupramoxAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Eurohealthcare Exponents, Inc. | DR-XY21578-B | Oct 22, 2027 | |
TeramoxylAmoxicillin (as Trihydrate) | 100 mg/ mL Powder for Suspension (Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY11083 | Jun 20, 2031 | |
TeramoxylAmoxicillin (Trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-X9749 | Apr 7, 2029 | |
TeramoxylAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for Oral SuspensionAmber Bottle x 60 mL Box of 1's; Amber Bottle x 105 mL Box of 1's | Rx | Drugmaker's Laboratories, Inc.Philippines | Terramedic, Inc. | DR-XY4717 | May 10, 2030 | |
TeramoxylAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY250 | Mar 20, 2032 | |
TermoxAmoxicillin (as trihydrate) | 100 mg / mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-17353 | Sep 9, 2027 | |
TermoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Box of 1-Amber Bottle x 10 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY18126-B | Sep 9, 2027 | |
TermoxAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY13308-B | Sep 10, 2027 | |
TermoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY15615-B | Aug 16, 2027 | |
TermoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-17352 | Aug 16, 2027 | |
TGMOXAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-1425-16 | Nov 21, 2026 | |
TgmoxAmoxicillin (as trihydrate) | 500mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-1431-07 | Aug 2, 2027 | |
TrexilAmoxicillin (as Trihydrate) | 125mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Novagen Pharmaceutical Co., Inc.Philippines | Medic + Aid Distributors Inc. | DRP-667-2 | Jul 4, 2027 | |
TrexilAmoxicillin (as Trihydrate) | 250mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Novagen Pharmaceutical Co., Inc.Philippines | Medic+Aid Distributors Inc. | DRP-666-02 | Jul 4, 2027 | |
Trixen-100Amoxicillin (as Trihydrate) | 100 mg/ mL Powder for Suspension15 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Kaufmann Pharma Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-8450-03 | Sep 30, 2027 | |
Trixen-125Amoxicillin (as trihydrate) | 125 mg/ 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Kaufmann Pharma Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-8466-01 | Sep 27, 2027 | |
Trixen-250Amoxicillin (as trihydrate) | 250 mg/ 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Kaufmann Pharma Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-8465-02 | Sep 27, 2027 | |
UnbrandedAmoxicillin (as trihydrate) | 250 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Diamond Laboratories Inc.Metro Manila | — | DRP-7649 | Jul 2, 2032 | |
UnbrandedAmoxicillin (as trihydrate) | 250 mg/ 5 mL Powder for SuspensionUL Standard Amber Glass Bottle with Aluminum Pilfer-Proof Cap x 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY12368 | Sep 14, 2031 | |
UnbrandedAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Dyna Drug Corporation | DRP-1425-13 | Nov 21, 2031 | |
UnbrandedAmoxicillin (as trihydrate) | 250mg/5mL Granules for Oral SuspensionType III Borosilicate amber bottle x 60mL Box of 1's | Rx | Fortis Medi Pharmaceutical, Inc.Philippines | — | DR-XY46629 | Jul 1, 2029 | |
UnbrandedAMOXICILLIN (AS TRIHYDRATE) | 250MG/5ML POWDER FOR SUSPENSION | Rx | J.M. TOLMANN LABORATORIES INC. | FARMACIA NI DOK, INC. | DRP-1425-12 | Nov 21, 2026 | |
UnbrandedAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | South Star DrugTrader: Innogen Pharmaceuticals, Inc. | DRP-10399-02 | May 6, 2031 | |
UNIMOXAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/ PVC Blister Pack x 10's (Box of 10's) | Rx | UNI MEDICOLABS.India | Medethix Inc.Importer: I.E MEDICA INC. | DRP-8614-01 | Apr 1, 2029 | |
ValzimoxAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Dropper x 10 mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | IAE PHARMACEUTICALS CORPORATION | DRP-1217-05 | Jun 28, 2027 | |
ValzimoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | Trader: IAE PHARMACEUTICALS CORPORATION | DR-XY20150 | Jun 19, 2028 | |
VaroloxAmoxicillin (as Trihydrate) | 125mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Novagen Pharmaceutical Co., Inc.Philippines | — | DRP-667 | Jul 4, 2027 | |
VaroloxAmoxicillin (as Trihydrate) | 250mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Novagen Pharmaceutical Co., Inc.Philippines | — | DRP-666 | Jul 4, 2027 | |
VaxmanAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Dropper x 10 mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | — | DRP-10662 | Jun 3, 2028 | |
VaxmanAmoxicillin (as trihydrate) | 125mg/5mL Powder for SuspensionAmber Glass Bottle w/ Silver Aluminum Cap x 60 mL (Box of 1's) | Rx | J.M. Tolamann Laboratories, Inc.Philippines | — | DRP-10661 | Oct 30, 2027 | |
VaxmanAmoxicillin (As Trihydrate) | 250mg/5mL Powder For SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-10727 | May 22, 2027 | |
VaxmanAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's); Blister Pack x 21's (Box of 21's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | — | DRP-1475 | May 10, 2027 | |
Vhellox 250Amoxicillin (as trihydrate) | 250 mg CapsuleBlister pack x 10’s (Box of 100’s) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-317 | Feb 5, 2028 | |
Vhellox 500Amoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s Box of 100’s | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-316 | Mar 10, 2029 | |
VinmoxAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Vincare PharmaTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-2392-01 | Jan 19, 2030 | |
VistrepAmoxicillin (as trihydrate) | 100 mg/mL Powder for SuspensionAmber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DR-XY18200-B | Nov 27, 2029 | |
VistrepAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for Oral Suspension60 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DR-XY18051-B | Nov 27, 2027 | |
VistrepAmoxicillin (as Trihydrate) | 250 mg/ 5 mL Powder for SolutionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, IncPhilippines | Trader: Vitalink Health Products, Inc. | DR-XY18050-B | Nov 27, 2031 | |
VistrepAmoxicillin (as Trihydrate) | 500 mg CapsuleBlister Pack x 10's (Bottler of 100's) | Rx | Lloyd Laboratories, IncPhilippines | Trader: Vitalink Health Products, Inc. | DR-XY18052-B | Dec 11, 2031 | |
VistrepAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DR-XY46975 | Aug 6, 2030 | |
VoxilAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | CHMI Pharma, Inc. | DRP-1431-04 | Aug 2, 2027 | |
WelmoxAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber glass bottle with dropper x 10mL in 15mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Phil. Pharmawealth, Inc. | DRP-5253-02 | Nov 19, 2027 | |
WelmoxAmoxicillin (as Trihydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Phil. Pharmawealth, Inc. | DRP-5251-02 | Feb 28, 2027 | |
WestfimoxAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)15 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-8450 | Sep 30, 2027 | |
WestfimoxAmoxicillin (as trihydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-8466 | Sep 27, 2027 | |
WestfimoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-8465 | Sep 27, 2027 | |
WestfimoxAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DR-XY46973 | Aug 6, 2031 | |
WestfimoxAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-5147 | Sep 19, 2027 | |
WinamoxAmoxicillin (as Trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Dropper x 10 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | — | DRP-1217 | Jun 28, 2027 | |
WINAMOXAMOXICILLIN (as Trihydrate) | 125 mg / 5 ml Powder for SuspensionBoston Round Amber Bottle with aluminum cap x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Metro Manila | — | DRP-1212 | Nov 13, 2031 | |
WinamoxAmoxicillin (as Trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-1425 | Nov 21, 2031 | |
WinamoxAmoxicillin (as trihydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | FIRSTMED THERACONCEPT INC. | DRP-1431 | Aug 2, 2027 | |
XentraMoxAmoxicillin (as trihydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Xentra Medica Cebu Corp.Trader: Solvang Pharmaceuticals, Inc. | DRP-17353-01 | Sep 9, 2027 | |
XentramoxAmoxicillin (as trihydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Xentra Medica Cebu Corp.Trader: Solvang Pharmaceuticals, Inc. | DRP-17352-01 | Aug 16, 2027 | |
XillinbestAmoxicillin (as trihydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-4087-05 | Nov 6, 2027 | |
ZerrsoxAmoxicillin (as Trihydrate) | 500 mg CapsuleAlu-PVC blister pack x 10's (Box of 100's) | Rx | Pharmatechnica Laboratory Inc.Philippines | — | DRP-11875 | Nov 14, 2028 | |
(no brand name)Amoxicillin (as Trihydrate) | 250mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Fortis Medi Pharmaceutical, Inc.Philippines | Importer: HEXAGON DISTRIBUTING CORPORATION | DR-XY47646 | Jan 7, 2027 | |
(no brand name)Amoxicillin (As Trihydrate) | 500mg CapsuleAlu/Alu Blister pack x 10's | Rx | — | — | DRP-8614 | Apr 1, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
United States (label)
Dosage forms and strengths (US label) US FDA label
3 DOSAGE FORMS AND STRENGTHS Amoxicillin: Tablets: 500 mg, 875 mg. Each tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Each film-coated, capsule-shaped, pink tablet is debossed with AMOXIL centered over 500 or 875, respectively. The 875-mg tablet is scored on the reverse side. For Oral Suspension: 200 mg/5 mL, 400 mg/5 mL.
Each 5 mL of reconstituted bubble-gum flavored suspension contains 200 mg or 400 mg amoxicillin as the trihydrate. Chewable Tablets: 125 mg – Each 125 mg cherry-banana-peppermint flavored tablet contains 125 mg of amoxicillin as the trihydrate. Each pale pink, oval tablet is imprinted with AMOXIL on one side and 125 on the other. 200 mg – Each 200 mg cherry-banana-peppermint flavored tablet contains 200 mg of amoxicillin as the trihydrate.
Each pale pink, round convex tablet is imprinted with AMOXIL and 200 along the edge of 1 side. 250 mg – Each 250 mg cherry-banana-peppermint flavored tablet contains 250 mg of amoxicillin as the trihydrate. Each pale pink, oval tablet is imprinted with AMOXIL on one side and 250 on the other. 400 mg – Each 400 mg cherry-banana-peppermint flavored tablet contains 400 mg of amoxicillin as the trihydrate.
Each pale pink, round convex tablet is imprinted with AMOXIL and 400 along the edge of 1 side. Tablets: 500 mg, 875 mg (3) For Oral Suspension: 200 mg/5 mL, 400 mg/5 mL (3) Chewable Tablets:125 mg, 200 mg, 250 mg, 400 mg (3)
Warnings/Precautions
- Anaphylactic reactions: Serious and occasionally fatal anaphylactic reactions have been reported in patients on penicillin therapy, including amoxicillin. Discontinue Amoxicillin if a reaction occurs (5.1). Severe cutaneous adverse reactions (SCAR): Monitor closely. Discontinue if rash progresses. (5.2)
- Drug-induced enterocolitis syndrome (DIES) has been reported with amoxicillin use. If this occurs, discontinue Amoxicillin and institute appropriate therapy. (5.3)
- Clostridioides difficile -associated diarrhea (CDAD)(ranging from mild diarrhea to fatal colitis): Evaluate if diarrhea occurs. (5.4)
5.1 Anaphylactic Reactions
5.1 Anaphylactic Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy including amoxicillin. Although anaphylaxis is more frequent following parenteral therapy, it has occurred in patients on oral penicillins. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens.
There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins. Before initiating therapy with amoxicillin, careful inquiry should be made regarding previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens.
If an allergic reaction occurs, amoxicillin should be discontinued, and appropriate therapy instituted.
5.2 Severe Cutaneous Adverse Reactions
5.2 Severe Cutaneous Adverse Reactions Amoxicillin may cause severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If patients develop skin rash they should be monitored closely, and amoxicillin discontinued if lesions progress.
5.3 Drug-Induced Enterocolitis Syndrome (DIES)
5.3 Drug-Induced Enterocolitis Syndrome (DIES) Drug-induced enterocolitis syndrome (DIES) has been reported with amoxicillin use [see Adverse Reactions (6.2)], with most cases occurring in pediatric patients < 18 years of age. DIES is a non-IgE mediated hypersensitivity reaction characterized by protracted vomiting occurring 1 to 4 hours after drug ingestion in the absence of skin or respiratory symptoms.
DIES may be associated with pallor, lethargy, hypotension, shock, diarrhea within 24 hours after ingesting amoxicillin, and leukocytosis with neutrophilia. If DIES occurs, discontinue Amoxicillin and institute appropriate therapy.
5.4 Clostridioides difficile
5.4 Clostridioides difficile -Associated Diarrhea (CDAD) Clostridioides difficile- associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including amoxicillin, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.
C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial use.
Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibacterial use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
5.5 Development of Drug-Resistant Bacteria
5.5 Development of Drug-Resistant Bacteria Prescribing amoxicillin in the absence of a proven or strongly suspected bacterial infection or prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
5.6 Skin Rash in Patients with Mononucleosis
5.6 Skin Rash in Patients with Mononucleosis A high percentage of patients with mononucleosis who receive amoxicillin develop an erythematous skin rash. Thus, amoxicillin should not be administered to patients with mononucleosis.
5.7 Phenylketonurics
5.7 Phenylketonurics Aamoxicillin chewable tablets contain aspartame which contains phenylalanine. Each 200 mg chewable tablet contains 1.82 mg phenylalanine; each 400 mg chewable tablet contains 3.64 mg phenylalanine. The oral suspension formulations of Amoxicillin do not contain phenylalanine and can be used by phenylketonurics.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Probenecid | Avoid | Blocks tubular secretion; higher and longer drug levels (label). | Coadministration not recommended. |
| Warfarin and other oral anticoagulants | Adjust or monitor | Prolonged prothrombin time / higher INR reported (label). | Monitor INR. |
| Allopurinol | Minor | More skin rash with ampicillin-class drugs (label). | Usually no action; counsel. |
| Oral contraceptives | Minor | May reduce contraceptive efficacy (label). | Counsel on backup contraception. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewed- Co-administration with probenicid is not recommended. (7.1)
- Concomitant use of amoxicillin and oral anticoagulants may increase the prolongation of prothrombin time. (7.2)
- Co-administration with allopurinol increases the risk of rash. (7.3)
- Amoxicillin may reduce the efficacy of oral contraceptives. (7.4)
7.1 Probenecid
7.1 Probenecid Probenecid decreases the renal tubular secretion of amoxicillin. Concurrent use of amoxicillin and probenecid may result in increased and prolonged blood levels of amoxicillin.
7.2 Oral Anticoagulants
7.2 Oral Anticoagulants Abnormal prolongation of prothrombin time (increased international normalized ratio [INR]) has been reported in patients receiving amoxicillin and oral anticoagulants. Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation.
7.3 Allopurinol
7.3 Allopurinol The concurrent administration of allopurinol and amoxicillin increases the incidence of rashes in patients receiving both drugs as compared to patients receiving amoxicillin alone. It is not known whether this potentiation of rashes is due to allopurinol or the hyperuricemia present in these patients.
7.4 Oral Contraceptives
7.4 Oral Contraceptives Amoxicillin may affect the intestinal flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives.
7.5 Other Antibacterials
7.5 Other Antibacterials Chloramphenicol, macrolides, sulfonamides, and tetracyclines may interfere with the bactericidal effects of penicillin. This has been demonstrated in vitro; however, the clinical significance of this interaction is not well documented.
7.6 Effects on Laboratory Tests
7.6 Effects on Laboratory Tests High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using CLINITEST ®, Benedict’s Solution, or Fehling’s Solution. Since this effect may also occur with amoxicillin, it is recommended that glucose tests based on enzymatic glucose oxidase reactions (such as CLINISTIX ®) be used.
Following administration of ampicillin or amoxicillin to pregnant women, a transient decrease in plasma concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol has been noted.
Adverse reactions
Common
- Diarrhea, nausea, vomiting
- Rash
Serious
- Anaphylaxis; severe cutaneous adverse reactions
- Drug-induced enterocolitis syndrome
- Clostridioides difficile-associated diarrhea
- Rash in infectious mononucleosis (avoid)
- The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions [see Warnings and Precautions (5.1)] Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.2)] Drug-Induced Enterocolitis Syndrome (DIES) [see Warnings and Precautions (5.3)] Clostridioides difficile -Associated Diarrhea (CDAD) [see Warnings and Precautions (5.4)] The most common adverse reactions (greater than 1%) observed in clinical trials of amoxicillin tablets or oral suspension were diarrhea, rash, vomiting, and nausea. (6.1)
- To report SUSPECTED ADVERSE REACTIONS, contact USAntibiotics, LLC at 1-844-454-5532 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
6.1 Clinical Trials Experience
6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most common adverse reactions (greater than 1%) observed in clinical trials of amoxicillin tablets or oral suspension were diarrhea, rash, vomiting, and nausea.
Triple therapy: The most frequently reported adverse events for patients who received triple therapy (amoxicillin/clarithromycin/ lansoprazole) were diarrhea (7%), headache (6%), and taste perversion (5%). Dual therapy: The most frequently reported adverse events for patients who received double therapy amoxicillin/lansoprazole were diarrhea (8%) and headache (7%).
For more information on adverse reactions with clarithromycin or lansoprazole, refer to the Adverse Reactions section of their package inserts.
6.2 Postmarketing Experience
6.2 Postmarketing Experience In addition to adverse events reported from clinical trials, the following events have been identified during postmarketing use of penicillins. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to amoxicillin.
Infections and Infestations: Mucocutaneous candidiasis. Gastrointestinal: Drug-induced enterocolitis syndrome (DIES), black hairy tongue, and hemorrhagic/pseudomembranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment [see Warnings and Precautions (5.4)]. Immune: Hypersensitivity reactions, anaphylactic/anaphylactoid reactions (including shock), angioedema, serum sickness-like reactions (urticaria or skin rash accompanied by arthritis, arthralgia, myalgia, and frequently fever), hypersensitivity vasculitis [see Warnings and Precautions (5.1)].
Skin and Appendages: Rashes, pruritus, urticaria, erythema multiforme, SJS, TEN, DRESS, AGEP, exfoliative dermatitis, and linear IgA bullous dermatosis. Liver: A moderate rise in AST and/or ALT has been noted, but the significance of this finding is unknown. Hepatic dysfunction including cholestatic jaundice, hepatic cholestasis and acute cytolytic hepatitis have been reported.
Renal: Crystalluria has been reported [see Overdosage (10)]. Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena.
Central Nervous System: Reversible hyperactivity, agitation, anxiety, insomnia, confusion, convulsions, behavioral changes, aseptic meningitis, and/or dizziness have been reported. Miscellaneous: Tooth discoloration (brown, yellow, or gray staining) has been reported. Most reports occurred in pediatric patients. Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.
Monitoring parameters
- Kidney function for dose; rash; diarrhea (CDAD); INR with oral anticoagulants (label). Crystalluria and interstitial nephritis reported after overdose; keep fluid intake up. Kidney
- Kidney function for dose
- INR with oral anticoagulants
Pharmacokinetics
Key PK parameters
| Half-life | About 61 minutes |
|---|---|
| Protein binding | About 20% |
| Renal excretion kidney | About 60% of an oral dose in urine in 6 to 8 hours, mostly unchanged |
| Dialyzability kidney | Yes (hemodialysis; label) |
Metabolism and Excretion : The half-life of amoxicillin is 61.3 minutes.
Approximately 60% of an orally administered dose of amoxicillin is excreted in the urine within 6 to 8 hours.
Since most of the amoxicillin is excreted unchanged in the urine, its excretion can be delayed by concurrent administration of probenecid [see Drug Interactions ( 7.1 ) ]. 12.4 Microbiology Mechanism of Action Amoxicillin is similar to penicillin in its bactericidal action against susceptible bacteria during the stage of active multiplication.
Pharmacokinetics (US label) US FDA label
12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Amoxicillin is an antibacterial drug [see Microbiology (12.4)]. 12.3 Pharmacokinetics Absorption: Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. The effect of food on the absorption of amoxicillin from the tablets and suspension of amoxicillin has been partially investigated; 400 mg and 875 mg formulations have been studied only when administered at the start of a light meal.
Orally administered doses of 250 mg and 500 mg amoxicillin capsules result in average peak blood levels 1 to 2 hours after administration in the range of 3.5 mcg/mL to 5.0 mcg/mL and 5.5 mcg/mL to 7.5 mcg/mL, respectively. Mean amoxicillin pharmacokinetic parameters from an open, two-part, single-dose crossover bioequivalence study in 27 adults comparing 875 mg of AMOXICILLIN with 875 mg of AUGMENTIN ® (amoxicillian//clavulanate potassium) showed that the 875 mg tablet of AMOXIL produces an AUC 0-∞ of 35.4 ± 8.1 mcg•hr/mL and a C max of 13.8 ± 4.1 mcg/mL.
Dosing was at the start of a light meal following an overnight fast. Orally administered doses of amoxicillin suspension, 125 mg/5 mL and 250 mg/5 mL, result in average peak blood levels 1 to 2 hours after administration in the range of 1.5 mcg/mL to 3.0 mcg/mL and 3.5 mcg/mL to 5.0 mcg/mL, respectively. Oral administration of single doses of 400 mg chewable tablets and 400 mg/5 mL suspension of amoxicillin to 24 adult volunteers yielded comparable pharmacokinetic data: Table 4: Mean Pharmacokinetic Parameters of AMOXIL (400 mg chewable tablets and 400 mg/5 mL suspension) in Healthy Adults * Administered at the start of a light meal. † Mean values of 24 normal volunteers.
Peak concentrations occurred approximately 1 hour after the dose. Dose* AUC 0-∞ (mcg·hr/mL) C max (mcg/mL) † Amoxicillin Amoxicillin (±S.D.) Amoxicillin (�S.D.) 400 mg (5 mL of suspension) 17.1 (3.1) 5.92 (1.62) 400 mg (1 chewable tablet) 17.9 (2.4) 5.18 (1.64) Distribution: Amoxicillin diffuses readily into most body tissues and fluids, with the exception of brain and spinal fluid, except when meninges are inflamed.
In blood serum, amoxicillin is approximately 20% protein-bound. Following a 1-gram dose, and utilizing a special skin window technique to determine levels of the antibiotic, it was noted that therapeutic levels were found in the interstitial fluid. Metabolism and Excretion: The half-life of amoxicillin is 61.3 minutes. Approximately 60% of an orally administered dose of amoxicillin is excreted in the urine within 6 to 8 hours.
Detectable serum levels are observed up to 8 hours after an orally administered dose of amoxicillin. Since most of the amoxicillin is excreted unchanged in the urine, its excretion can be delayed by concurrent administration of probenecid [see Drug Interactions (7.1)]. 12.4 Microbiology Mechanism of Action Amoxicillin is similar to penicillin in its bactericidal action against susceptible bacteria during the stage of active multiplication.
It acts through the inhibition of cell wall biosynthesis that leads to the death of the bacteria. Resistance Resistance to amoxicillin is mediated primarily through enzymes called beta-lactamases that cleave the beta-lactam ring of amoxicillin, rendering it inactive. Antimicrobial Activity Amoxicillin has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections [see Indications and Usage (1)].
Gram-Positive Bacteria Enterococcus faecalis Staphylococcus spp. Streptococcus pneumoniae Streptococcus spp. (alpha and beta-hemolytic) Gram-Negative Bacteria Escherichia coli Haemophilus influenzae Helicobacter pylori Proteus mirabilis Susceptibility Test Methods: For specific information regarding susceptibility test interpretive criteria and associated test methods and quality control standards recognized by FDA for this drug, please see: https://www.fda.gov/STIC.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Amoxicillin 100 mg/mL, 15 mL Drops | ₱16.00–₱23.00Reference ₱19.80 | per unit | DPRI procurement range |
| Amoxicillin 250 mg Capsule | ₱1.00–₱1.80Reference ₱1.06 | per capsule | DPRI procurement range |
| Amoxicillin 250 mg/5 mL, 60 mL Suspension | ₱15.07–₱94.62Reference ₱20.48 | per unit | DPRI procurement range |
| Amoxicillin 500 mg Capsule | ₱1.19–₱4.48Reference ₱1.28 | per capsule | DPRI procurement range |
| 100 mg/mL (as trihydrate) granules/powder for drops in 15 mL | ₱58.25 | per unit | PhilHealth GAMOT fixed fee |
| 250 mg (as trihydrate) capsule | ₱4.00 | per capsule | PhilHealth GAMOT fixed fee |
| 250 mg/5 mL (as trihydrate) granules/powder for suspension in 60 mL | ₱92.50 | per unit | PhilHealth GAMOT fixed fee |
| 500 mg (as trihydrate) capsule | ₱5.25 | per capsule | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Amoxicillin (as trihydrate) |
| PNF listing | Oral: 250 mg and 500 mg capsule |
| PNF listing | Oral: 100 mg/mL granules/powder for drops (suspension), 15 mL |
| PNF listing | Oral: 250 mg/5 mL granules/powder for suspension,60 mL |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
| PhilHealth YAKAP (formerly Konsulta) | Yes |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Amoxicillin · USAntibiotics, LLC [US FDA-approved label, version 5, July 7, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06e5c07d-d95c-4955-8d35-a4703ca2359e
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- USAntibiotics, LLC. (2026). Amoxicillin capsules, tablets and powder for oral suspension [Prescribing information; US FDA-approved label, NDA050760, set ID 06e5c07d-d95c-4955-8d35-a4703ca2359e, version effective July 7, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06e5c07d-d95c-4955-8d35-a4703ca2359e
- Li, P. K.-T., Chow, K. M., Cho, Y., Fan, S., Figueiredo, A. E., Harris, T., Kanjanabuch, T., Kim, Y.-L., Madero, M., Malyszko, J., Mehrotra, R., Okpechi, I. G., Perl, J., Piraino, B., Runnegar, N., Teitelbaum, I., Wong, J. K.-W., Yu, X., & Johnson, D. W. (2022). ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dialysis International, 42(2), 110–153. https://doi.org/10.1177/08968608221080586
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .
